learndrugs
Respiratory

COPD

COPD High-yield Verified · Sep 2026

COPD is a common, preventable, and treatable disease of persistent, usually progressive airflow limitation, caused by abnormalities of the airways (bronchitis, bronchiolitis) and/or alveoli (emphysema) and experienced as chronic breathlessness, cough, sputum, and flare-ups.

The third leading cause of morbidity and mortality worldwide, and the disorder where nursing school myths go to die: learn the real oxygen story, the exacerbation triad, and the two mechanisms under one obstruction umbrella.

What’s going wrong in the body

The normal physiology, where it fails, and why the body’s compensation backfires.

01 One umbrella, two diseases

COPD is not a single lesion — it is persistent, mostly irreversible airflow obstruction produced by some combination of two processes: small airway disease (chronic bronchitis, obstructive bronchiolitis) and parenchymal destruction (emphysema). The relative contribution varies from patient to patient, and most people with COPD have both.

Both processes grow from the same root: an amplified, dysregulated inflammatory response to inhaled noxious particles — cigarette smoke above all. Recruited immune cells release proteases (neutrophil elastase, matrix metalloproteinases), reactive oxygen species, and proinflammatory cytokines (IL-8, TNF-α, IL-6, IL-1β). What that inflammatory soup attacks — the alveolar walls or the airway lining — decides which face of COPD dominates.

The fork: one inflammatory response, two targets — alveolar destruction and airway mucus disease — converging on obstruction and trapped air.

02 Emphysema — the walls come down

Emphysema is a protease–antiprotease imbalance. Normally, alpha-1 antitrypsin neutralizes neutrophil elastase before it can digest lung tissue. When smoke-driven inflammation floods the lung with elastase — or when AAT is genetically deficient — the excess enzyme causes permanent destruction of alveolar walls distal to the terminal bronchiole: abnormal, permanent enlargement of the air spaces with loss of elasticity, without fibrosis.

Here is the key mechanical insight: those elastic alveolar walls were what held the small airways open during exhalation. With the recoil gone, airways collapse dynamically on every breath out — air gets in but can’t get out. The result is gas trapping and hyperinflation: the barrel chest, the hyperresonant percussion note, the distant breath sounds, and the long, pursed-lip exhale are all this one mechanism made visible.

The distribution tells you the cause. Centrilobular emphysema is the most common pattern and is smoking-associated; panacinar emphysema with basilar predominance points to alpha-1 antitrypsin deficiency; paraseptal emphysema is the pattern associated with spontaneous pneumothorax.

03 Chronic bronchitis — the airways drown in mucus

Chronic bronchitis is defined clinically: a productive cough on most days for at least 3 months in 2 consecutive years. Underneath that definition, chronic irritation drives goblet cell hyperplasia and metaplasia plus submucosal gland hypertrophy — the mucus factories multiply and enlarge (the Reid index of gland-to-wall thickness rises above the normal < 0.4, and MUC5B mucin production climbs).

More mucus meets less clearance: the mucociliary escalator is damaged, so secretions pool, airways stay inflamed, and the walls remodel with peribronchiolar fibrosis. Inflamed, thickened, mucus-plugged small airways obstruct flow just as surely as collapsing ones do — the same downstream story of trapped air, but by a different route.

This phenotype is also a progression warning: smokers with chronic bronchitis carry a 2-fold risk of developing new airflow obstruction, and about half of smokers with chronic bronchitis go on to develop COPD.

04 Living with trapped air — the compensations and their price

Poorly ventilated lung regions create a V/Q problem, and the lung compensates with hypoxic pulmonary vasoconstriction — clamping down perfusion to poorly oxygenated regions so blood is routed to alveoli that can still oxygenate it. Locally and briefly, that is smart. Chronically and lung-wide, it is a disaster: sustained vasoconstriction drives smooth-muscle proliferation in the small pulmonary arteries, pulmonary vascular resistance climbs, and the right ventricle — built for a low-pressure circuit — hypertrophies and eventually fails. That is cor pulmonale, and COPD is its predominant cause.

Meanwhile the kidneys quietly compensate for chronically retained CO₂ by retaining bicarbonate, buffering the pH back toward normal. This is why a stable COPD patient’s ABG shows an elevated PaCO₂ and an elevated HCO₃⁻ with a near-normal pH — a compensated chronic respiratory acidosis. It is also why chronic retainers tolerate startling CO₂ levels: symptoms may not appear until PaCO₂ exceeds 90 mmHg, versus about 75 mmHg in a normal person.

The spiral: a helpful local compensation, made chronic and global, becomes the pulmonary hypertension that breaks the right heart.

05 The oxygen story, done right

Generations of students were taught to fear oxygen in COPD because it would "knock out the hypoxic drive to breathe." That explanation is a persistent and unfounded myth — and acting on it kills patients, because hypoxemia kills first. Oxygen should never be withheld from a hypoxemic, dyspneic COPD patient; acute titration is unlikely to alter respiratory drive in the first 24 hours.

Excessive oxygen can raise CO₂ — but through different mechanisms. High FiO₂ releases hypoxic pulmonary vasoconstriction everywhere at once, so blood flows back into bad lung units: V/Q mismatch and alveolar dead space increase. At the same time the Haldane effect kicks in — oxygenated hemoglobin carries less CO₂, so CO₂ is unloaded into plasma — and minute ventilation drifts down. The answer to all of this is not less oxygen than the patient needs; it is titrated oxygen: target SpO₂ 88–92%, ideally via a Venturi mask for precise FiO₂, avoiding uncontrolled high flow.

The exam-critical decision flow: treat hypoxemia, titrate to 88–92%, and answer rising CO₂ with titration and NIV — never with no oxygen.

Causes & risk factors

Modifiable factors are teaching targets — the patient can act on them.

Tobacco smoking — the dominant cause (~70–80% of cases in high-income countries; symptoms typically after ≥ 20 pack-years) modifiable Secondhand smoke exposure modifiable Biomass fuel combustion (leading global risk factor in resource-limited countries) modifiable Occupational exposures — coal dust, silica, cadmium, isocyanates modifiable Air pollution and chemical fumes/dusts modifiable Severe childhood lower respiratory infections Alpha-1 antitrypsin deficiency — the most prevalent Mendelian genetic risk factor (~1–2% of cases; panacinar, basilar emphysema, often young or minimal smoking history)

Signs & symptoms

Each finding tied to the mechanism that produces it — and the triage it calls for.

Progressive dyspnea — first with exertion, eventually at rest early Expected
Why: Trapped air and destroyed gas-exchange surface can’t meet rising demand; the cardinal symptom, advancing to rest dyspnea in severe disease.
Chronic cough — often the very first symptom early Expected
Why: Airway inflammation and pooled secretions trigger cough long before obstruction is measurable; may be intermittent at first.
Sputum — mucoid at baseline Expected
Why: Hyperplastic goblet cells and hypertrophied submucosal glands overproduce mucus that damaged cilia can’t clear. A change to purulent sputum is an exacerbation cue, not baseline.
Prolonged expiratory phase with expiratory wheeze Expected
Why: Airways narrow and collapse on the way out — exhalation through obstructed tubes is slow and noisy (E:I beyond 1:3).
Barrel chest (increased AP diameter) late Expected
Why: Chronic hyperinflation reshapes the thorax — the trapped air literally holds the chest in inspiration.
Hyperresonance to percussion · distant breath and heart sounds Expected
Why: Over-aerated lung transmits percussion like a drum and muffles auscultation; cardiac and hepatic dullness shrink.
Accessory muscle use · Hoover sign late
Why: Scalenes and sternocleidomastoids are recruited to move air; a flattened diaphragm pulls the lower rib cage paradoxically inward on inspiration (Hoover sign).
Pursed-lip breathing Hold & notify
Why: A self-taught fix: slow exhalation through pursed lips creates a small positive end-expiratory pressure (PEEP) that splints collapsing airways open. Significantly increased pursed-lip breathing may signal respiratory distress or impending respiratory failure.
Tripod positioning — leaning forward, arms braced Report immediately
Why: Bracing the arms stabilizes the shoulder girdle so the sternocleidomastoid and scalenes can pull the sternum, clavicle and rib cage upward to assist ventilation. A recognized field sign of obvious respiratory distress and impending failure.
Cachexia without cyanosis (emphysema-predominant, the classic "pink puffer") late
Why: Emphysema-predominant patients tend to be cachectic and noncyanotic, working hard through pursed lips; cachexia is an independent mortality predictor.
Cyanosis · hepatomegaly · asterixis (severe chronic-bronchitis-predominant disease) late Hold & notify
Why: End-stage bronchitic disease brings hypoxemic cyanosis, right-heart congestion of the liver, and the flapping tremor of severe hypercapnia.
Increased dyspnea + increased sputum volume + new purulence Hold & notify
Why: The cardinal exacerbation triad — all three together marks the most severe (type 1) exacerbation. This is the pattern the nurse reports, not watches.
New somnolence, headache, confusion, or slowing respirations Report immediately
Why: Rising CO₂ depresses the brain — early CO₂ narcosis. Drowsiness in a COPD patient on oxygen is an ABG, not a nap.
New digital clubbing — NOT an expected COPD finding Hold & notify
Why: Uncomplicated COPD is not among clubbing’s associated conditions. New clubbing (Lovibond angle > 180°, lost Schamroth window) warrants provider evaluation — lung malignancy is the most common pulmonary cause in adults.

Diagnostics

Test In this disorder Normal
Spirometry (post-bronchodilator) The bronchodilator-first step is the point: obstruction that fully reverses is asthma’s story, not COPD’s. GOLD also groups by exacerbation history — Group E = ≥ 2 moderate exacerbations, or ≥ 1 requiring hospitalization, in the past year FEV1/FVC < 0.70 after a short-acting bronchodilator confirms the diagnosis — non-fully reversible obstruction. Severity by FEV1 % predicted: GOLD 1 ≥ 80% · GOLD 2 50–79% · GOLD 3 30–49% · GOLD 4 < 30% GOLD 2026 FEV1/FVC ≥ 0.70
ABG Draw when FEV1 < 50% predicted, SpO₂ < 95% on room air, or any clinical sign of respiratory failure. Chronic retainers may stay asymptomatic until PaCO₂ > 90 mmHg — trend against the patient’s baseline, not the textbook’s Chronic retainer pattern: PaCO₂ > 45 mmHg (hypercapnia) with elevated HCO₃⁻ and near-normal pH — a renally compensated respiratory acidosis StatPearls PaCO₂ ≤ 45 mmHg
Chest X-ray The film shows the trapped air, not the obstruction — spirometry makes the diagnosis Hyperinflation: flattened diaphragms, increased retrosternal air space, horizontal ribs, attenuated peripheral vascular markings, bullae —
Blood eosinophil count This single lab steers whether an inhaled corticosteroid joins the dual bronchodilator ≥ 300 cells/µL predicts strong ICS benefit · 100–299 modest benefit · < 100 ICS unlikely to help and pneumonia risk may outweigh benefit GOLD 2026 —
Alpha-1 antitrypsin level Check at least once in every COPD patient — urgently if diagnosed under 45, minimal smoking history, lower-lobe emphysema, or unexplained liver disease < 11 µmol/L (≈ < 57 mg/dL) is consistent with significant deficiency StatPearls —
DLCO (diffusing capacity) Distinguishes emphysema’s parenchymal loss from purely airway disease Reduced in emphysema — the alveolar-capillary membrane itself has been destroyed —

Complications

Warning: Acute exacerbation (AECOPD) Hold & notify
The most common and most impactful complication: an acute flare in which breathlessness, cough, and sputum worsen over days, sometimes with a fast pulse and fast breathing.
Severity is typed by the cardinal triad — more dyspnea, more sputum volume, new purulence (all 3 = severe/type 1; 2 = moderate; 1 plus URI signs, fever, wheeze, more cough, or a > 20% rise in HR or RR = mild). Each hospitalized exacerbation carries roughly 43% excess mortality risk in the following year and accelerates FEV1 decline — report the triad early, anticipate nebulized bronchodilators, systemic steroids, and antibiotics if sputum is purulent.
Warning: CO₂ narcosis → hypercapnic respiratory failure Report immediately
Excessive CO₂ depresses consciousness: nonspecific headache, somnolence or tachypnea early; delirium, bradypnea, coma and death if untreated. Asterixis accompanies severe hypercapnia.
The nurse’s move: treat new drowsiness or confusion as a stat-ABG finding, titrate oxygen back toward SpO₂ 88–92% (never off), and anticipate NIV for hypercapnic respiratory failure. Remember the chronic retainer may not look sick until PaCO₂ is extreme.
Warning: Cor pulmonale Hold & notify
Right-ventricular hypertrophy and failure from COPD-driven pulmonary hypertension — chronic hypoxemic vasoconstriction remodels the small pulmonary arteries. COPD is the predominant cause.
Watch for the heralds: exertional dyspnea and fatigue, new ankle edema, JVD with a prominent V wave, loud pulmonic S2, parasternal lift, hepatomegaly, exertional syncope. Oxygen therapy relieves the hypoxemic vasoconstriction and improves cardiac output — one more reason LTOT matters.
Warning: Pneumothorax Report immediately
Bullous emphysema markedly raises pneumothorax risk, and the paraseptal pattern is specifically associated with spontaneous pneumothorax.
Sudden new unilateral chest pain with abruptly worsening dyspnea in an emphysema patient is a collapsed lung until proven otherwise — rapid assessment and immediate provider notification.
Caution: The company COPD keeps
Secondary polycythemia from chronic hypoxemia (raised viscosity, thromboembolic risk), cachexia (an independent mortality predictor), anxiety/depression in up to 40%, lung cancer at 2–5× risk independent of smoking, and comorbid cardiovascular disease.
Perspective for prioritizing: cardiovascular disease is the leading cause of death in mild-moderate COPD, and lung cancer is the most common cause of COPD-related death in that same group — screen, assess mood, and never dismiss chest symptoms as "just the COPD."

Medications for this condition

Why each class is prescribed here — every card links to its full pharmacology page.

Bronchodilators First-line
Respiratory · albuterol

The foundation of COPD therapy at every stage: SABAs (albuterol) give rapid rescue bronchodilation, LABAs give 12–24-hour maintenance, and LABA + LAMA dual therapy is the preferred maintenance regimen for most symptomatic patients — single-inhaler combinations are available. In an exacerbation, short-acting bronchodilators are increased in dose and frequency, by spacer or air-driven nebulizer.
Anticholinergics (Atropine) First-line
Autonomic · atropine

The other half of dual bronchodilation: LAMAs (tiotropium, umeclidinium, aclidinium, glycopyrronium) provide 24-hour maintenance bronchodilation as the LAMA in LABA + LAMA. In an acute exacerbation, the SAMA ipratropium is nebulized with the SABA — every 20 minutes initially, then every 4–6 hours — the standard inpatient combination.
Inhaled Corticosteroids
Respiratory · fluticasone

Never monotherapy in COPD — the opposite of asthma. ICS is added to the LABA + LAMA backbone for exacerbation-prone (Group E) patients, steered by blood eosinophils: consider triple therapy at ≥ 300 cells/µL (or 100–299 with persistent exacerbations, or concurrent asthma); avoid when eosinophils are < 100, with recurrent pneumonia, or with NTM disease, where pneumonia risk may outweigh benefit.

Beyond medications

  • Smoking cessation — the ONLY intervention consistently shown to slow FEV1 decline and reduce COPD mortality. Support every attempt; nicotine replacement and pharmacotherapy reliably increase long-term abstinence.
  • Vaccinations — yearly influenza, plus pneumococcal, COVID-19, RSV, and Tdap vaccines as the current CDC/ACIP adult schedule recommends — fewer infections mean fewer exacerbations.
  • Pulmonary rehabilitation — indicated at mMRC ≥ 2 or a symptom score (CAAT, formerly CAT) ≥ 10; builds exercise capacity the disease steals.
  • Long-term oxygen therapy (LTOT) — for resting PaO₂ ≤ 55 mmHg or SpO₂ ≤ 88%, or PaO₂ 56–59 mmHg with cor pulmonale, pulmonary hypertension, or polycythemia (Hct > 55%). Used 15 or more hours per day it improves survival.
  • Breathing retraining — pursed-lip breathing (see teaching) and positioning that recruits accessory muscles effectively.
  • Nocturnal NIV — considered for stable chronic hypercapnia (PaCO₂ ≥ 52 mmHg).

Nursing considerations

The RN-specific layer — each action paired with the reason it matters.

Assessment & monitoring
Learn this patient’s baseline: usual SpO₂, sputum character, dyspnea level, and mental status — then trend against it.
Why: A chronic retainer lives at numbers that would alarm you in anyone else; change from baseline, not distance from textbook normal, is the signal.
Titrate oxygen to SpO₂ 88–92%, and question orders or habits that push a retainer to 99%.
Why: Titrated oxygen improves outcomes; uncontrolled high flow worsens V/Q mismatch and (via the Haldane effect) raises CO₂. The target is a window, not a ceiling of 100%.
Track the exacerbation triad every shift: dyspnea trend, sputum volume, sputum color.
Why: More dyspnea + more sputum + new purulence is the cardinal exacerbation pattern — catching it early is the difference between a med change and a hospitalization that carries ~43% excess one-year mortality.
Treat new somnolence, morning headache, confusion, or a slowing respiratory rate as a stat-ABG finding.
Why: These are the early face of CO₂ narcosis; bradypnea in a previously tachypneic patient is decompensation, not improvement.
Watch the right heart: daily weights, new ankle edema, JVD, hepatomegaly.
Why: New systemic congestion in a COPD patient heralds cor pulmonale — pulmonary hypertension has reached the right ventricle.
Note how much pursed-lip breathing and positioning the patient needs.
Why: Significantly increased pursed-lip breathing may indicate respiratory distress or impending failure, and tripod positioning is a recognized distress sign — these are assessment data, not quirks.
During an exacerbation
Apply oxygen immediately — never withhold it — titrated to SpO₂ 88–92%, ideally by Venturi mask.
Why: Hypoxemia kills first, and the "oxygen destroys their drive to breathe" rule is a refuted myth; the real risks (V/Q worsening, Haldane effect) are managed by titration, not deprivation.
Give nebulized SABA + SAMA (albuterol + ipratropium) as ordered — every 20 minutes initially, then every 4–6 hours.
Why: Combined short-acting bronchodilation is the standard first move of exacerbation care; dose and frequency are increased over baseline.
Anticipate prednisone 40 mg daily × 5 days, and antibiotics if sputum is purulent (azithromycin, doxycycline, or amoxicillin-clavulanate, 5–7 days).
Why: Five days of steroid is noninferior to fourteen (REDUCE trial); purulence is the trigger that adds the antibiotic.
Get serial ABGs and continuous pulse oximetry; anticipate NIV or high-flow oxygen if CO₂ climbs or the patient tires.
Why: The exacerbation that fails nebulizers becomes hypercapnic respiratory failure — NIV is the bridge that prevents intubation, and blood gases are how you see it coming.
Monitor fluid balance, maintain VTE prophylaxis (SC heparin/LMWH), and assess for the mimics and companions: heart failure, arrhythmias, pulmonary embolism.
Why: GOLD exacerbation care is supportive care plus vigilance — an immobile, hypoxemic, polycythemic patient is thrombosis-prone, and not every worsening dyspnea is the COPD.
Patient teaching
Make every encounter a smoking-cessation encounter; connect the patient to nicotine replacement or cessation pharmacotherapy.
Why: Quitting is the only intervention that slows the loss of lung function — everything else manages symptoms and exacerbations.
Teach pursed-lip breathing: keep the neck and shoulders relaxed, breathe in slowly and deeply through the nose, then breathe out gently and slowly through pursed lips so the exhale is longer than the inhale.
Why: The slow pursed exhale creates a small PEEP that splints floppy airways open — less trapped air, less work of breathing, better gas exchange, on demand and drug-free.
Teach the report-now triad: breathing harder than usual, more sputum, or sputum turning yellow-green — call before it becomes an ER visit.
Why: Patients who recognize the exacerbation triad get treated as outpatients; each hospitalization accelerates lung-function decline and carries real mortality.
Keep vaccinations current: influenza yearly, plus pneumococcal, COVID-19, RSV, and Tdap vaccines as the current CDC/ACIP adult schedule recommends.
Why: Respiratory infections — mostly viral — trigger most exacerbations, so preventing them prevents flare-ups.
If on home oxygen: wear it 15 or more hours per day, at the prescribed flow — not just "when short of breath."
Why: LTOT extends life only at adequate daily duration; it also relieves the hypoxic vasoconstriction driving cor pulmonale.
Attend pulmonary rehabilitation and keep moving between sessions.
Why: Rehab rebuilds the exercise capacity and confidence that dyspnea-avoidance erodes — deconditioning makes every breath more expensive.

How a real nurse thinks

The clinical-judgment loop, worked for a typical presentation — reasoning, not reference.

  1. 1
    Recognize cues

    The cues that matter: SpO₂ 84% with RR 26 and accessory muscle use, tripod positioning (a recognized sign of obvious respiratory distress), the full exacerbation triad (worse dyspnea + more sputum + new purulence), and an ABG showing PaCO₂ 59 with HCO₃⁻ 31. The mildly elevated BP and 37.4 °C are background. The new RN’s question is itself a cue — a dangerous myth is about to delay oxygen.

  2. 2
    Analyze cues

    The ABG tells a two-part story: PaCO₂ 59 is well above 45 — respiratory acidosis — but HCO₃⁻ 31 with a pH of only 7.33 means her kidneys have been compensating for a long time. She is a chronic retainer having an acute, infection-flavored exacerbation (all three cardinal symptoms present = severe/type 1 pattern). The hypoxemia (PaO₂ 50) is the immediate threat — hypoxemia kills first, and withholding oxygen over the hypoxic-drive myth would treat the folklore instead of the patient.

  3. 3
    Prioritize

    Oxygenation outranks everything: SpO₂ 84% gets treated now, titrated to the 88–92% window. Then bronchodilation, then the systemic therapies. Sequence: oxygen titrated to target → nebulized SABA + SAMA → steroid and antibiotic per orders → monitoring plan for CO₂. Correcting the new RN happens in the same breath as applying the oxygen.

  4. 4
    Generate solutions

    Apply the Venturi mask and titrate FiO₂ until SpO₂ sits at 88–92% — not 99%; give the albuterol/ipratropium nebulizer; verify the prednisone and azithromycin are given; set continuous pulse oximetry with a plan for serial mental-status checks; know the escalation path — if CO₂ climbs or she tires, the next step is NIV, not less oxygen.

  5. 5
    Take action

    Oxygen goes on immediately, titrated into the target window; the nebulizer follows. To the new RN: "Never withhold O₂ from a hypoxemic COPD patient — the hypoxic-drive story is a myth. If her CO₂ rises on oxygen it’s from V/Q changes and the Haldane effect, and the answer is titrating to 88–92% and watching her, not leaving her at 84%." Document baseline mental status explicitly — it is the early-warning system for CO₂ narcosis.

  6. 6
    Evaluate

    Success looks like: SpO₂ holding 88–92%, respiratory rate drifting down, wheeze easing after nebulizers, and the patient alert at every check. Re-escalation triggers: new drowsiness, confusion, or headache (get a stat ABG — early CO₂ narcosis), a slowing respiratory rate, or SpO₂ that won’t hold in the window — anticipate NIV, never oxygen removal.

Scenario — you’re the nurse

Work each question before revealing the answer. Rationales explain the wrong options too.

Medical unit · 1900, start of night shift

A 71-year-old woman admitted this afternoon with a COPD exacerbation. History: GOLD 3 COPD (FEV1 40% predicted), 50 pack-years, still smoking. Three days of worsening dyspnea; sputum increased and turned yellow-green. Orders: O₂ titrated to SpO₂ 88–92% via Venturi mask, nebulized albuterol/ipratropium, prednisone 40 mg PO daily, azithromycin, repeat ABG in the morning.

1900 vitals — HR 104 · BP 142/84 · RR 26 · SpO₂ 84% on room air · T 37.4 °C
Assessment — sitting leaned forward over the bedside table, arms braced; pursed-lip breathing; prolonged exhalation with expiratory wheeze; accessory muscle use
Admission ABG (room air) — pH 7.33 · PaCO₂ 59 mmHg · HCO₃⁻ 31 mEq/L · PaO₂ 50 mmHg
Sputum — thick, yellow-green, increased from baseline per patient
New RN comment — "Her sat is 84%, but she’s a CO₂ retainer… should we hold off on oxygen so we don’t knock out her drive to breathe?"
Q1 Select all that apply
At 1900, which findings require follow-up? Select all that apply.
  1. A. SpO₂ 84% on room air
  2. B. Blood pressure 142/84 mmHg
  3. C. Sitting leaned forward over the bedside table with arms braced
  4. D. HCO₃⁻ 31 mEq/L on the admission ABG
  5. E. Sputum increased in volume and now yellow-green
Reveal answer & rationale
Answer: A, C, E
SpO₂ 84% is significant hypoxemia demanding immediate titrated oxygen. Tripod positioning is a recognized sign of obvious respiratory distress, not a comfort preference. The sputum change completes the cardinal exacerbation triad and drives the antibiotic decision. The BP (B) is mildly elevated background noise, and the elevated HCO₃⁻ (D) is expected — it is the renal compensation of a chronic CO₂ retainer, evidence of chronicity rather than a new problem.
Q2 Multiple choice
The admission ABG (pH 7.33 · PaCO₂ 59 · HCO₃⁻ 31 · PaO₂ 50) is best interpreted as:
  1. A. Acute respiratory acidosis with no compensation
  2. B. Metabolic alkalosis with respiratory compensation
  3. C. Respiratory acidosis with renal (metabolic) compensation, plus significant hypoxemia
  4. D. A normal ABG for any older adult
Reveal answer & rationale
Answer: C
PaCO₂ 59 (> 45 mmHg) makes this a respiratory acidosis, and the elevated HCO₃⁻ of 31 shows the kidneys have been retaining bicarbonate to pull the pH back toward normal — the signature of a chronic retainer (C). PaO₂ 50 adds the acute threat. Uncompensated acute acidosis (A) would show a normal HCO₃⁻ and a much lower pH. In metabolic alkalosis (B) the pH would be high, not low. And (D) — hypercapnia with a PaO₂ of 50 is never a normal ABG at any age.
Q3 Multiple choice
The new RN suggests holding oxygen because the patient "is a CO₂ retainer and O₂ could knock out her drive to breathe." The best response is:
  1. A. Agree — keep her on room air and recheck the SpO₂ in 30 minutes
  2. B. Apply oxygen but only at the lowest possible flow, keeping SpO₂ near 84–86% to be safe
  3. C. Apply oxygen now, titrated to SpO₂ 88–92% — the hypoxic-drive explanation is a refuted myth, and hypoxemia is the immediate threat
  4. D. Apply high-flow oxygen to bring the SpO₂ to 99% as fast as possible
Reveal answer & rationale
Answer: C
Oxygen is never withheld from a hypoxemic, dyspneic COPD patient; the target is the 88–92% window, and acute titration is unlikely to alter respiratory drive in the first 24 hours (C). Waiting on room air (A) leaves her at a PaO₂ of 50 — hypoxemia kills first. Deliberately under-titrating below target (B) is the same myth in smaller print. Uncontrolled high flow to 99% (D) swings to the opposite error: it worsens V/Q mismatch and, via the Haldane effect, can genuinely raise CO₂ — titration is the whole point.
Q4 Put in order
Put the nurse’s first four actions in priority order:
  1. A. Give the ordered albuterol/ipratropium nebulizer
  2. B. Apply the Venturi mask and titrate oxygen to SpO₂ 88–92%
  3. C. Verify the prednisone and azithromycin have been given
  4. D. Document assessment findings and the patient’s baseline mental status
Reveal answer & rationale
Correct order: B → A → C → D
Oxygenation first: SpO₂ 84% is the immediate physiologic threat and titrated O₂ is the fastest correction (B). The combined SABA + SAMA nebulizer (A) opens the airways next. The steroid and antibiotic (C) treat the exacerbation over days, not minutes. Documentation (D) — including baseline mental status, the early-warning reference for CO₂ narcosis — matters but never precedes stabilization. Starting with the nebulizer (A first) treats bronchospasm while leaving the patient profoundly hypoxemic.
Q5 Multiple choice
At 2300 the patient’s SpO₂ reads 96% — a colleague turned the FiO₂ up "so she could rest easier." She is now difficult to rouse, with RR 12. The best action is:
  1. A. Let her sleep — the work of breathing has exhausted her, and rest promotes recovery
  2. B. Remove the oxygen completely and stimulate her until the SpO₂ falls to the low 80s
  3. C. Titrate the FiO₂ back down toward the 88–92% target, obtain a stat ABG, notify the provider, and anticipate NIV
  4. D. Increase the FiO₂ further, since her level of consciousness suggests she needs more oxygen
Reveal answer & rationale
Answer: C
New somnolence with a slowing respiratory rate in a CO₂ retainer whose oxygen was pushed above target is CO₂ narcosis until proven otherwise: excess FiO₂ worsened V/Q matching and the Haldane effect unloaded CO₂ into her blood. The response is titration back to 88–92%, a stat ABG, and readiness for NIV (C) — depressed consciousness from CO₂ is treated by supporting ventilation, not by either extreme. "Letting her sleep" (A) is the classic fatal miss — this is narcosis, not rest. Stopping oxygen entirely (B) trades hypercapnia for the hypoxemia that kills faster. More oxygen (D) deepens the mechanism that caused the problem.

Common questions

What causes copd?
Common causes and risk factors include tobacco smoking — the dominant cause (~70–80% of cases in high-income countries; symptoms typically after ≥ 20 pack-years), secondhand smoke exposure, biomass fuel combustion (leading global risk factor in resource-limited countries), occupational exposures — coal dust, silica, cadmium, isocyanates, air pollution and chemical fumes/dusts, and others.
What are the early signs of copd?
Early findings include Progressive dyspnea — first with exertion, eventually at rest, Chronic cough — often the very first symptom.
Which findings should a nurse report immediately in copd?
Report immediately: Tripod positioning — leaning forward, arms braced, New somnolence, headache, confusion, or slowing respirations, CO₂ narcosis → hypercapnic respiratory failure, Pneumothorax. These signal deterioration that needs rapid intervention.
Is it safe to give oxygen to a patient with COPD?
Yes — and it is unsafe to withhold it. The old teaching that oxygen "knocks out the hypoxic drive to breathe" is a refuted myth. Oxygen-induced CO₂ rises come from V/Q changes and the Haldane effect, and the answer is titration to SpO₂ 88–92% (ideally by Venturi mask), not oxygen restriction. A hypoxemic, dyspneic COPD patient gets oxygen immediately.
What is the difference between emphysema and chronic bronchitis?
Both live under the COPD umbrella and most patients have some of each. Emphysema is destruction of the alveolar walls: elastic recoil is lost, so airways collapse on exhalation and air gets trapped. Chronic bronchitis is defined by a productive cough on most days for ≥ 3 months in 2 consecutive years, driven by mucus-gland overgrowth and failed mucociliary clearance. Different lesions, same result — airflow obstruction.
Can COPD be cured or reversed?
No — there is no cure, and the airflow obstruction is not fully reversible. But quitting smoking is the one intervention consistently shown to slow the decline in lung function and reduce mortality, and long-term oxygen therapy (15+ hours/day) prolongs survival in patients with severe resting hypoxemia. Everything else — bronchodilators, rehab, vaccination — manages symptoms and prevents exacerbations.

Sources

Reviewed by Hae Suk Lee, RN

Educational summary for nursing students. Scenarios are fictional teaching cases. Always verify against current guidelines and your institution's protocols before acting in practice. Not medical advice.

Bookmark LearnDrugs.com?

Your saved pages are kept in this browser. Add LearnDrugs.com to your browser’s bookmarks to get back to them in one click.

Drag this link to your bookmarks bar: LearnDrugs.com

Or press Ctrl + D to bookmark the page you’re on.